Table 1 Criteria for evaluation of adherence to guidelines

Pharmacological management

 First line uterotonic: oxytocin in step1

 Second line uterotonic: sulprostone (prostaglandin E2 analogue) in step2

 No misoprostol (prostaglandin E1 analogue) in any step

Non-pharmacological management

 Manual placental delivery, manual examination of the uterine cavity in step1

 No intrauterine tamponade in step 1

 No torsion of the cervix in step 1

 Uterine massage in steps 1 or 2

 Cervical examination with speculum in steps 1 or 2

 No surgical treatment in steps 1 or 2

 No selective arterial embolization in steps 1or 2

 Surgical treatment, selective arterial embolization and/or intrauterine tamponade in step 3

Communication, monitoring and investigation:

 Alert other members of the team in steps 1 or 2

 Venipuncture with blood count, hemostasis in steps 1 or 2

 Resuscitation measure in steps 1 or 2